Proteomics involves the large-scale study of proteins, typically using technologies like mass spectrometry and protein microarrays. In cancer diagnosis, proteomics can identify specific protein signatures or biomarkers that are indicative of the presence of cancer. For instance, elevated levels of certain proteins in the blood can signal the early stages of breast or prostate cancer, allowing for earlier and more effective intervention.
